These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 10428117)

  • 21. Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989.
    Robert CF; Déglon JJ; Wintsch J; Martin JL; Perrin L; Bourquin M; Gabriel V; Hirschel B
    AIDS; 1990 Jul; 4(7):657-60. PubMed ID: 2397058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ongoing HIV and viral hepatitis infections in IDUs across the EU, 2001-2005.
    Wiessing L; Nardone A
    Euro Surveill; 2006 Nov; 11(11):E061123.2. PubMed ID: 17213556
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
    Fuglsang T; Fouchard JR; Ege PP
    Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
    [TBL] [Abstract][Full Text] [Related]  

  • 24. HIV infection in injecting drug users.
    Durante A
    AIDS Care; 1991; 3(4):439-41. PubMed ID: 1786279
    [No Abstract]   [Full Text] [Related]  

  • 25. Getting hip to hep.
    Lyerla R; Weinbaum C
    Surviv News (Atlanta Ga); 2001 Nov; ():16. PubMed ID: 11769057
    [No Abstract]   [Full Text] [Related]  

  • 26. Estimating national-level syringe availability to injecting drug users and injection coverage: Switzerland, 1996-2006.
    Arnaud S; Jeannin A; Dubois-Arber F
    Int J Drug Policy; 2011 May; 22(3):226-32. PubMed ID: 21600753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Who: four ways to reduce hepatitis infections in people who inject drugs.
    Cent Eur J Public Health; 2012 Sep; 20(3):207. PubMed ID: 23285521
    [No Abstract]   [Full Text] [Related]  

  • 28. Seroprevalence and seroincidence of HIV-1 in injection drug users using the VA system.
    Hartigan PM; Hamilton JD
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S215-7. PubMed ID: 7865304
    [No Abstract]   [Full Text] [Related]  

  • 29. Substance use among women at risk for HIV infection.
    Wambach KG; Byers JB; Harrison DF; Levine P; Imershein AW; Quadagno DM; Maddox K
    J Drug Educ; 1992; 22(2):131-46. PubMed ID: 1625113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infectious diseases and public health: risk-taking behavior during participation in the Swiss program for a medical prescription of narcotics (PROVE).
    Steffen T; Christen S; Blättler R; Gutzwiller F;
    Subst Use Misuse; 2001 Jan; 36(1-2):71-89. PubMed ID: 11305355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Hepatitis and HIV infection in users of illegal drugs].
    Scheitlin T; Joller-Jemelka HI; Grob PJ
    Schweiz Med Wochenschr; 1992 Sep; 122(39):1432-45. PubMed ID: 1411402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Declining prevalence of HIV infection among injecting drug users entering drug treatment in Italy: 1990-1991.
    Rezza G; De Rose A; Dorrucci M; Arpino C; Serafin I
    Eur J Epidemiol; 1993 Nov; 9(6):663-6. PubMed ID: 8150071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Infectious diseases and drug abuse. Prevention and treatment in the drug abuse treatment system.
    Haverkos HW
    J Subst Abuse Treat; 1991; 8(4):269-75. PubMed ID: 1787552
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Substitution Treatment of Injecting Opioid Users for Prevention of HIV Infection.
    Barajas-Nava L
    J Assoc Nurses AIDS Care; 2017; 28(5):832-833. PubMed ID: 28652132
    [No Abstract]   [Full Text] [Related]  

  • 35. Overcoming barriers to prevention, care, and treatment of hepatitis C in illicit drug users.
    Edlin BR; Kresina TF; Raymond DB; Carden MR; Gourevitch MN; Rich JD; Cheever LW; Cargill VA
    Clin Infect Dis; 2005 Apr; 40 Suppl 5(Suppl 5):S276-85. PubMed ID: 15768335
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differences in the incidence of hepatitis B and human immunodeficiency virus infections among injecting drug users.
    Levine OS; Vlahov D; Brookmeyer R; Cohn S; Nelson KE
    J Infect Dis; 1996 Mar; 173(3):579-83. PubMed ID: 8627020
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HIV seroprevalence and risk factors among clients of female and male prostitutes.
    Elifson KW; Boles J; Darrow WW; Sterk CE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):195-200. PubMed ID: 10048908
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C among risk groups for HIV and hepatitis B.
    Vanderschueren S; Van Renterghem L; Plum J; Verhofstede C; Mak R; Vincke J
    Int J STD AIDS; 1991; 2(3):185-7. PubMed ID: 1650587
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Illicit drug injectors' strategies for cleaning needles and syringes: findings from qualitative research.
    Hughes R
    Scand J Public Health; 2000 Jun; 28(2):158-60. PubMed ID: 10954144
    [No Abstract]   [Full Text] [Related]  

  • 40. The effects of HIV infection on the development of methadone maintenance treatment in Spain.
    Torrens M; Camí J
    Addiction; 1994 Dec; 89(12):1707-8. PubMed ID: 7866257
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.